Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review. (2021)
Attributed to:
Reducing relapse in alcohol dependence with the NMDA receptor antagonist, ketamine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1192/bjo.2021.1061
PubMed Identifier: 35048815
Publication URI: http://europepmc.org/abstract/MED/35048815
Type: Journal Article/Review
Volume: 8
Parent Publication: BJPsych open
Issue: 1
ISSN: 2056-4724